A Research Award Highlights a Quiet Frontier in the Science Behind Diabetes Drugs
Agilent’s recognition of UC Davis chemist Marie Heffern underscores how the stability of peptide medicines—especially incretin-based therapies—relies on scientific questions that often unfold far from...